What is the recommended injectable medication and dose for treating persistent hiccups in an adult?

Injectable Treatment for Persistent Hiccups

For persistent hiccups requiring injectable therapy, use metoclopramide 5-20 mg IV, which can be titrated up to a maximum of 3-4 administrations daily, or chlorpromazine 25-50 mg IV/IM (though chlorpromazine is the only FDA-approved agent for hiccups, metoclopramide has better evidence and safety profile). 1

Evidence-Based Approach

The treatment landscape for persistent hiccups is surprisingly limited despite how distressing this condition can be. Here's what the evidence actually shows:

First-Line Injectable Options

Metoclopramide is your best-supported injectable option:

• Dose: 5-20 mg IV, titrated as needed 1
• Frequency: Up to 3-4 administrations daily 2, 1
• Supported by a randomized controlled trial showing significantly higher efficacy than placebo (relative risk 2.75,95% CI: 1.09-6.94, P = 0.03) 3
• Mild adverse events include fatigue, upset mood, and dizziness 3
• Works via dopamine receptor antagonism and prokinetic effects

Chlorpromazine is the only FDA-approved agent but has more concerning side effects:

• Dose: 25-50 mg IV or IM (typical dosing from clinical practice)
• Sedating effects can impair rehabilitation and daily function 4
• Supported by observational data but lacks high-quality RCT evidence 5

Alternative Injectable: Prochlorperazine

• Dose: 5-10 mg IV 1
• Can be titrated to 3-4 administrations daily 1
• Another dopamine antagonist option with similar mechanism to metoclopramide

Clinical Decision Algorithm

1. Start with metoclopramide 10 mg IV - best balance of efficacy and safety
2. Assess response at 4-8 hours - if no improvement, give second dose
3. If refractory after 48 hours of metoclopramide:
   • Consider chlorpromazine 25-50 mg IV/IM, OR
   • Switch to oral gabapentin (see below for refractory cases)

Critical Caveats

The evidence is surprisingly weak: A systematic review found no adequately powered, well-designed trials for most treatments 5. Only baclofen and metoclopramide have been studied in randomized controlled trials, and both were small studies 6, 5.

For truly refractory cases (>48 hours despite standard agents), emerging evidence suggests:

• Levetiracetam 1000 mg IV loading dose, then 500 mg IV q12h showed complete resolution within 8 hours in post-traumatic brain injury hiccups unresponsive to chlorpromazine, metoclopramide, and haloperidol 7
• This is very recent (2026) case report evidence but represents a potential rescue option

Oral alternatives may be more appropriate for persistent cases:

• Gabapentin 100-400 mg TID has good case series support 4
• Baclofen has RCT evidence but requires oral administration 5

Common Pitfalls to Avoid

• Don't use chlorpromazine first-line in rehabilitation settings - sedation impairs participation 4
• Don't forget to address underlying causes - GERD, metabolic abnormalities, CNS lesions 5
• Don't continue ineffective therapy beyond 48 hours - escalate or change agents 7
• Watch for extrapyramidal side effects with dopamine antagonists, especially in elderly patients

The bottom line: Start with metoclopramide 10-20 mg IV for its superior evidence base and safety profile over chlorpromazine, despite chlorpromazine being the only FDA-approved option. 3, 5